
Sign up to save your podcasts
Or


AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
By The Motley Fool4.7
16041,604 ratings
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.

3,217 Listeners

1,482 Listeners

808 Listeners

944 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,715 Listeners

195 Listeners

833 Listeners

84 Listeners

584 Listeners

1,049 Listeners

56 Listeners